Dry Eye Disease

NEW ORLEANS — Recent years have brought several significant advances in dry eye disease treatment, Amy Lin, MD, said during Cornea Subspecialty Day at the American Academy of Ophthalmology meeting.

NEW ORLEANS — John F. Doane, MD, offered SMILE pearls for new surgeons during a presentation at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology meeting.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Michelle Senchyna, PhD, vice president of clinical development and medical affairs at Aerie, discusses phase 2b study results for AR-15512 in dry eye disease.

Reproxalap achieved the primary endpoint of improved ocular redness in patients with dry eye disease in a phase 2 clinical trial, according to a press release from Aldeyra Therapeutics.

BOSTON – The majority of subjects surveyed indicated they experienced a dry eye flare at least once during a 12-month period, according to a poster at the American Academy of Optometry annual meeting.

BOSTON – Treatment with OC-01 nasal spray showed significant improvements in dry eye disease signs and symptoms, according to a data review presented at the American Academy of Optometry annual meeting.

BOSTON – It is an exciting time for anterior segment, Ora senior vice president George Ousler said here at the American Academy of Optometry annual meeting.

The effect of eye rubbing in children and FDA approvals lead Healio/OSN coverage in October.

OTX-CSI seems to be a safe treatment option for patients with dry eye disease, according to a speaker at the European Society of Cataract and Refractive Surgeons meeting.

When I write for myself, in my personal blog and elsewhere, I routinely begin by defining the terms I will be addressing. In order to have a useful discussion on any topic, it is important to agree on what it is that you are talking about.